Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level DNarrative ReviewPubMed
A Review of the Therapeutic Efficacy and Safety of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Models of Subacute and Chronic Myocardial Infarction.
Narrative Review on Cardiovascular Disease, published in J Cardiovasc Dev Dis (2026) — summary generated from the PubMed abstract.
- 2026
J Cardiovasc Dev Dis - Level BClinical TrialPubMed
Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study.
Clinical Trial with a reported sample of 24 on Tendon Injury, Rotator Cuff, published in J Shoulder Elbow Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
J Shoulder Elbow Surg - Level DAnimal StudyPubMed
Preclinical Assessment of Safety and Efficacy of Deferoxamine (DFO)-pretreated Feline Adipose Mesenchymal Stem Cells.
Animal Study on Chronic Inflammation, Immune Modulation, published in In Vivo (2025) — summary generated from the PubMed abstract.
- 2025
In Vivo - Level BClinical TrialPubMed
Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study.
Clinical Trial on Chronic Wound, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level DAnimal StudyPubMed
Bioscaffold developed with decellularized human amniotic membrane seeded with mesenchymal stromal cells: assessment of efficacy and safety profiles in a second-degree burn preclinical model.
Animal Study on Chronic Wound, Burns, published in Biofabrication (2022) — summary generated from the PubMed abstract.
- 2022
Biofabrication8 citations - Level BClinical TrialPubMed
Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles.
Clinical Trial, published in J Extracell Vesicles (2021) — summary generated from the PubMed abstract.
- 2021
J Extracell Vesicles - Level BClinical TrialPubMed
Preclinical assessment of safety and efficacy of intravenous delivery of autologous adipose-derived regenerative cells (ADRCs) in the treatment of severe thermal burns using a porcine model.
Clinical Trial with a reported sample of 15 on Chronic Wound, Burns, published in Burns (2018) — summary generated from the PubMed abstract.
- 2018
- n = 15
Burns15 citations - Level BClinical TrialEurope PMC
Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies
Clinical Trial, published in NPJ Regen Med (2017) — summary generated from the PubMed abstract.
- 2017
NPJ Regen Med38 citations - Level BClinical TrialEurope PMC
Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint
Clinical Trial on Osteoarthritis, published in Arthritis Res Ther (2016) — summary generated from the PubMed abstract.
- 2016
Arthritis Res Ther242 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406